Groupama Asset Managment Cuts Position in Healthpeak Properties, Inc. (NYSE:DOC)

Groupama Asset Managment trimmed its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 7.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 149,451 shares of the real estate investment trust’s stock after selling 12,496 shares during the quarter. Groupama Asset Managment’s holdings in Healthpeak Properties were worth $2,986,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of DOC. The Manufacturers Life Insurance Company purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at $13,062,000. FMR LLC bought a new position in Healthpeak Properties during the third quarter valued at about $67,058,000. Townsquare Capital LLC purchased a new stake in Healthpeak Properties during the third quarter worth about $226,000. Glenmede Trust Co. NA bought a new stake in Healthpeak Properties in the third quarter worth about $359,000. Finally, CreativeOne Wealth LLC purchased a new position in Healthpeak Properties in the third quarter valued at about $210,000. 93.57% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on DOC shares. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target for the company in a research note on Wednesday, January 15th. Mizuho decreased their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. Robert W. Baird dropped their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 11th. StockNews.com upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Saturday, March 22nd. Finally, Wedbush lowered their price objective on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 14th. Four research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Healthpeak Properties has an average rating of “Moderate Buy” and a consensus price target of $23.83.

Healthpeak Properties Trading Down 1.0 %

Shares of Healthpeak Properties stock opened at $20.02 on Wednesday. The company’s 50-day moving average price is $20.19 and its 200-day moving average price is $21.06. The company has a market cap of $14.00 billion, a price-to-earnings ratio of 57.19, a PEG ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a 12-month low of $17.80 and a 12-month high of $23.26. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96.

Healthpeak Properties Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were issued a $0.305 dividend. This represents a $1.22 annualized dividend and a yield of 6.10%. This is an increase from Healthpeak Properties’s previous quarterly dividend of $0.30. The ex-dividend date was Friday, February 14th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.